Xanthoangelol

There are no associated biomedical information in the current reference collection.

Current reference collection contains 157 references associated with Xanthoangelol in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Xanthoangelol

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Xanthoangelol

MeSH term MeSH ID Detail
Neuroblastoma D009447 66 associated lipids
Total 1

NCBI Entrez Crosslinks

All references with Xanthoangelol

Download all related citations
Per page 10 20 50 | Total 25
Authors Title Published Journal PubMed Link
pmid:
Kimura Y and Baba K Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol. 2003 Int. J. Cancer pmid:12845685
Akihisa T et al. Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects. 2003 Cancer Lett. pmid:14607326
Sugii M et al. Xanthoangelol D isolated from the roots of Angelica keiskei inhibits endothelin-1 production through the suppression of nuclear factor-kappaB. 2005 Biol. Pharm. Bull. pmid:15802795
Tabata K et al. Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells. 2005 Biol. Pharm. Bull. pmid:16079483
Ogawa H et al. Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats. 2007 Clin. Exp. Pharmacol. Physiol. pmid:17250645
Motani K et al. Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma. 2008 Biol. Pharm. Bull. pmid:18379052
Okuyama T et al. Anti-tumor-promotion by principles obtained from Angelica keiskei. 1991 Planta Med. pmid:1896522
Murakami S et al. Inhibition of gastric H+, K(+)-ATPase by chalcone derivatives, xanthoangelol and 4-hydroxyderricin, from Angelica keiskei Koidzumi. 1990 J. Pharm. Pharmacol. pmid:1982146
Kawabata K et al. Prenylated chalcones 4-hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation. 2011 Mol Nutr Food Res pmid:20938990